Long-term injuries to Luis Gil and Gerrit Cole will immediately test New York's pitching depth, with Giancarlo Stanton ...
“We’ve built 24 plasma injectors, created over 200,000 plasmas, and generated fusion neutrons from plasma compressions – de-risking LM26 and preparing us for this new chapter at General Fusion,” said ...
PyroGenesis Inc. (“PyroGenesis”) ( (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a high-tech company that designs, develops, manufactures and commercializes advanced all-electric plasma processes ...
2025 (GLOBE NEWSWIRE) -- General Fusion’s Magnetized Target Fusion (MTF) demonstration, Lawson Machine 26 (LM26), has successfully formed a magnetized plasma in the machine’s target chamber ...
For more information on the Phase 1b clinical trial, visit: https://clinicaltrials.gov/study/NCT06732180 ...
5d
The Print on MSNThis Bengaluru startup’s leading India’s nuclear fusion research—to light up a billion homesOnce mastered, nuclear fusion technology has the potential to change how humanity lives by providing a limitless, sustainable ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results